Evaluating the effect of a new supplement on recovery after open heart surgery

Not Applicable

• Conditions: I25.0, I25; T82.6, T82; Condition 1: Metabolic, infectious and oxidative complications of coronary artery bypass grafting surgery. Condition 2: Coronary Artery Disease.; Infection and inflammatory reaction due to cardiac valve prosthesis, Unspecified complication of cardiac and vascular prosthetic device, implant and graft; Atherosclerotic cardiovascular disease, Atherosclerotic heart disease, Chronic ischaemic heart disease, unspecified,

• Registration Number: IRCT201312102480N3
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 92

Inclusion Criteria

male and female patients in the range of 30 to 70 years old, undergoing coronary artery bypass grafting surgery,
exclusion criteria: Diabetes mellitus, Metabolic, hematological, and immune disorders, history of renal problem and CVA, taking antioxidant supplements, emergency operations, ejection fraction < 30%

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Plasma glucose level. Timepoint: measured in 5 steps: 1 week before surgery, on the day of surgery before anf after the operation, 1 week after surgery and 1 month after surgery. Method of measurement: spectrophotometric method.;Serum insulin level. Timepoint: measured in 5 steps: 1 week before surgery, on the day of surgery before anf after the operation, 1 week after surgery and 1 month after surgery. Method of measurement: Eliza.;Hemoglobin A1C. Timepoint: measured in 5 steps: 1 week before surgery, on the day of surgery before anf after the operation, 1 week after surgery and 1 month after surgery. Method of measurement: HPLC.;Body composition changes. Timepoint: measured in 4 steps: 1 week before surgery, on the day of surgery, 1 week after surgery and 1 month after surgery. Method of measurement: using Body impedance analyser, skinfold measurement with caliper, and Arm muscle circumference with tape meter.

Secondary Outcome Measures

Name	Time	Method
ipid peroxidatin level. Timepoint: measured in 5 steps: 1 week before surgery, on the day of surgery before anf after the operation, 1 week after surgery and 1 month after surgery. Method of measurement: TBARS method.